← All stocks

Ascendis Pharma A/S

ASND Net selling
CIK 0001612042 #733 in the set updated 17 Sep 2026
Bought (120 mo)
$777.07K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.51M
$0.00 on a plan · $810.57K straight out of an exercise
Sold at will
$4.70M
2 of 3 sales
Net
−$4.74M
−$3.93M against sales at will

By person

5 insiders · 12 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
JENSEN FLEMMING STEEN
See Remarks
$4.64M (1)
−$4.64M
0
0.0000%
$0.00
−100.0%
Bodenhoff Mads
SVP & PAO
$810.57K (1) scheduled
−$810.57K
0
0.0000%
$0.00
BIENAIME JEAN JACQUES
Director
$699.34K (7)
+$699.34K
2,900
0.0047%
$783.55K
SMITH SCOTT THOMAS
EVP & Chief Financial Officer
$77.73K (2)
+$77.73K
4,367
0.0070%
$1.18M
+8.7%
HOLTUG LARS
Director
$62.33K (1)
−$62.33K
4,000
0.0065%
$1.08M
−5.6%
Insider
Date
Role
Action
Shares
Price
Amount
Bodenhoff Mads
8 Sep 2026
SVP & PAO
Sold after exercise
3,000
$270.19
$810.57K
HOLTUG LARS
2 Sep 2026
Director
Sell
236
$264.13
$62.33K
BIENAIME JEAN JACQUES
14 Aug 2026
Director
Buy
900
$246.91
$222.22K
BIENAIME JEAN JACQUES
14 Aug 2026
Director
Buy
1,100
$245.85
$270.44K
SMITH SCOTT THOMAS
2 Jun 2026
EVP & Chief Financial Officer
Buy
100
$219.00
$21.90K
SMITH SCOTT THOMAS
29 May 2026
EVP & Chief Financial Officer
Buy
250
$223.32
$55.83K
BIENAIME JEAN JACQUES
29 May 2026
Director
Buy
100
$223.50
$22.35K
BIENAIME JEAN JACQUES
29 May 2026
Director
Buy
200
$222.30
$44.46K
BIENAIME JEAN JACQUES
29 May 2026
Director
Buy
200
$223.76
$44.75K
BIENAIME JEAN JACQUES
26 May 2026
Director
Buy
200
$239.37
$47.87K
BIENAIME JEAN JACQUES
26 May 2026
Director
Buy
200
$236.24
$47.25K
JENSEN FLEMMING STEEN
11 May 2026
See Remarks
Sell
19,460
$238.49
$4.64M

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 3,000
History held since 12 May 2026